Ceregene
USA
Ceregene is a biopharmaceutical company developing neurotropic growth factor treatments for major neurodegenerative disorders using a proprietary gene delivery technology. Therapies for Parkinson’s disease and Alzheimer’s disease are in clinical development.
- Sector: Healthcare
- Status: Private
- Geographic Market: U.S.
- Investment Year: 2007
- Board Representation: Ashley Friedman
- Investment Team: Richard Murphey